SENSEX NIFTY

Intas Pharmaceuticals

Nov 10, 2014 at 19:19 | Source: PTI
Temasek acquired the stake by way of secondary purchase of shares from private equity investor ChrysCapital.
Sep 16, 2014 at 15:13 | Source: PTI
According to the fair trade watchdog, "the proposed combination is not likely to have an appreciable adverse effort on competition in India".
Jun 20, 2013 at 12:05 | Source: Moneycontrol.com
Intas Pharmaceuticals that engaged in the development, manufacture and marketing of pharmaceutical formulations has filed IPO papers with SEBI.
Jun 14, 2013 at 20:30 | Source: PTI
The IPO will be made through a public issue of equity shares of Rs 10 each at a premium, to be determined through book building aggregating Rs 225 crore of fresh issue and an offer for sale of 11,621,100 equity shares by Mozart Ltd
Nov 08, 2011 at 22:23 | Source: CNBC-TV18
Faced with close competition from Dr Reddy's, Intas Pharma and Biocon, Reliance Lifesciences strategy to stand out is by offering the largest product pipeline in biosimilars. The Mukesh Ambani-led company is betting on non-insulin biosimilars to enlarge its footprint in India and emerging markets.
Jul 27, 2011 at 17:45 | Source: Moneycontrol.com
ICRA has assigned a grade 4 to the proposed IPO of Intas Pharmaceuticals (IPL), indicating above average fundamentals, in its research report.
Mar 29, 2011 at 13:09 | Source: VCCircle
ChrysCapital is selling half of its holding in Intas Pharmaceuticals in the public issue of the mid-sized drug-maker that is looking to raise Rs 425 crore through fresh issue of shares during the IPO.
Mar 28, 2011 at 17:09 | Source: Moneycontrol.com
Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) of its equity shares of face value Rs 10 each comprising a fresh issue of equity shares aggregating up to Rs 425 crore and an offer for sale of 5,810,550 equity shares by Mozart Limited.
Feb 06, 2009 at 16:18
Apotex Inc. of Canada and Intas Biopharmaceuticals Limited of India have extended their business agreement to develop a biosimilar version of pegfilgrastim, a protein that is used to treat neutropenia (a side effect of cancer chemotherapy).
Apr 09, 2008 at 15:35
Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of Neukine, biosimilar form of recombinant GCSF
Messages on Intas Pharmaceuticals »

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:VC Circle - The Ahmedabad-based pharma company is expected to use the money for expansion and a partial exit for the existing PE investor, ChrysCapital, which has about 16%. Intas Pharmaceuticals is in discussion with private equity (PE) investors for another

12.13 PM Jan 20th

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:Business Standard - City-based drugmaker Intas Pharmaceuticals has entered into a licensing deal with Australia`s Mayne Pharma Corporation to supply eleven injectables products for the Australian market. Jayesh Shah, chief financial officer of Intas Pharmaceuticals confirmed the development

2.47 PM Nov 3rd 2012

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:Business Standard - City-based drugmaker Intas Pharmaceuticals has entered into a licensing deal with Australia`s Mayne Pharma Corporation to supply eleven injectables products for the Australian market. Jayesh Shah, chief financial officer of Intas Pharmaceuticals confirmed the development

2.34 PM Nov 3rd 2012

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:Economic Times - NEW DELHI: The volatile market condition has also taken a toll on the fund raising plans of pharma and healthcare companies with several firms either withdrawing or deferring their initial public offers (IPO). Ahmedabad-based drug maker Intas Pharmaceuticals became

11.02 AM May 26th 2012

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:Economic Times - NEW DELHI: Private equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug maker deferred its IPO due to volatile market conditions. The deal will increase ChrysCapital`s holding in the company to over

12.58 PM Apr 26th 2012

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:Economic Times - Private equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug maker deferred its IPO due to volatile market conditions. The deal will increase ChrysCapital`s holding in the company to over 15% from 11

10.57 AM Apr 26th 2012

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:VC Circle - BY TEAM VCC Intas has deferred its IPO where it planned to raise Rs 425cr in fresh capital besides a secondary sale. Private equity major ChrysCapital is investing Rs 300 crore ($56.2 million) in Ahmedabad-based Intas Pharmaceuticals Ltd,

10.10 AM Apr 26th 2012

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:Economic Times - Private equity firm ChrysCapital is set to buy an additional stake in Intas Pharmaceuticals for about Rs 275-300 crore ahead of the Ahmedabad-based drug maker`s IPO which is likely to be deferred due to volatile market conditions. Although the stake could not be confirmed

2.22 PM Apr 25th 2012

arjun_mohit
e

Gold Member

11 Followers

Alembic Pharma  

planned. However, companies like Alembic Pharmaceuticals, Intas Pharmaceuticals and Dishman Pharmaceuticals claimed that they were very much on track when it came to launching products in the US market. R K Baheti, director, finance of Alembic Pharmaceuticals said that "We have actually factored

7.30 PM May 13th 2013

Web Messenger

Platinum Member

252740 Followers

News Now  

Source:Business Standard - Two Gujarat-based companies Claris Lifesciences and Intas Pharmaceuticals came under the National Pharmaceutical Pricing Authority (NPPA) net for overcharging prices of medicines flouting the ceiling fixed by the regulator. Minister of State for chemicals and fertilisers

7.34 PM Nov 26th 2012

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.